
Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.

Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.

A few key points differentiate between the symptoms of a cold, flu, or possible COVID-19 infection.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

The University of Pittsburgh’s Masters of Science in Pharmacy Business Administration program catalyzes the critical skills and expertise necessary for students to reach their professional goals.

Published: September 9th 2020 | Updated:

Published: October 12th 2016 | Updated: